Bain Capital Life Sciences Investors, LLC Q2 2024 Filing
Filed August 12, 2024
Portfolio Value
$910.8T
Holdings
25
Report Date
Q2 2024
Filing Type
13F-HR
All Holdings (25 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | NUVLNUVALENT INC | 2,697,267 | $204.6T | 22.46% | |
| 2 | NAMSNEWAMSTERDAM PHARMA COMPANY | 10,473,913 | $201.2T | 22.09% | |
| 3 | IRONDISC MEDICINE INC | 1,795,735 | $80.9T | 8.89% | |
| 4 | DNTHDIANTHUS THERAPEUTICS INC | 3,013,423 | $78.0T | 8.56% | |
| 5 | PHVSPHARVARIS N V | 3,303,381 | $62.1T | 6.82% | |
| 6 | YB4PSAVARA INC | 14,565,457 | $58.7T | 6.44% | |
| 7 | ANNXANNEXON INC | 8,449,208 | $41.4T | 4.55% | |
| 8 | KYTXKYVERNA THERAPEUTICS INC | 3,368,370 | $25.3T | 2.77% | |
| 9 | TNGXTANGO THERAPEUTICS INC | 2,892,663 | $24.8T | 2.72% | |
| 10 | SLDBSOLID BIOSCIENCES INC | 4,034,582 | $22.9T | 2.51% | |
| 11 | —MERSANA THERAPEUTICS INC | 8,663,673 | $17.4T | 1.91% | |
| 12 | SYRSSYROS PHARMACEUTICALS INC | 2,749,808 | $14.2T | 1.56% | |
| 13 | IPSCCENTURY THERAPEUTICS INC | 5,410,361 | $13.8T | 1.51% | |
| 14 | CABACABALETTA BIO INC | 1,649,964 | $12.3T | 1.35% | |
| 15 | ASNSUSDX4 PHARMACEUTICALS INC | 16,915,784 | $9.8T | 1.08% | |
| 16 | ARQTARCUTIS BIOTHERAPEUTICS INC | 1,030,703 | $9.6T | 1.05% | |
| 17 | AVIRATEA PHARMACEUTICALS INC | 2,485,638 | $8.2T | 0.90% | |
| 18 | RPIDRAPID MICRO BIOSYSTEMS INC | 8,434,560 | $5.6T | 0.61% | |
| 19 | CCCCC4 THERAPEUTICS INC | 1,111,910 | $5.1T | 0.56% | |
| 20 | NAUTNAUTILUS BIOTECHNOLOGY INC | 2,000,000 | $4.7T | 0.51% | |
| 21 | XLOXILIO THERAPEUTICS INC | 3,785,450 | $3.6T | 0.39% | |
| 22 | MRNS*MARINUS PHARMACEUTICALS INC | 2,267,680 | $2.7T | 0.29% | |
| 23 | IVVDINVIVYD INC | 1,799,595 | $2.0T | 0.22% | |
| 24 | ACRSACLARIS THERAPEUTICS INC | 1,000,000 | $1.1T | 0.12% | |
| 25 | NAMSNEWAMSTERDAM PHARMA COMPANY | 100,000 | $872.0B | 0.10% |